1. Home
  2. SNN vs AFRM Comparison

SNN vs AFRM Comparison

Compare SNN & AFRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Smith & Nephew SNATS Inc.

SNN

Smith & Nephew SNATS Inc.

N/A

Current Price

$34.54

Market Cap

14.3B

Sector

Health Care

ML Signal

N/A

Logo Affirm Holdings Inc.

AFRM

Affirm Holdings Inc.

N/A

Current Price

$57.91

Market Cap

14.3B

ML Signal

N/A

Company Overview

Basic Information
Metric
SNN
AFRM
Founded
1856
2012
Country
United Kingdom
United States
Employees
16988
N/A
Industry
Industrial Specialties
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
14.3B
14.3B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
SNN
AFRM
Price
$34.54
$57.91
Analyst Decision
Hold
Buy
Analyst Count
2
25
Target Price
$36.25
$85.87
AVG Volume (30 Days)
669.9K
4.8M
Earning Date
04-30-2026
05-07-2026
Dividend Yield
2.19%
N/A
EPS Growth
N/A
108.98
EPS
N/A
0.60
Revenue
N/A
$3,224,412,000.00
Revenue This Year
$8.61
$30.78
Revenue Next Year
$5.60
$24.14
P/E Ratio
$64.97
$93.10
Revenue Growth
N/A
38.80
52 Week Low
$25.45
$39.42
52 Week High
$38.79
$100.00

Technical Indicators

Market Signals
Indicator
SNN
AFRM
Relative Strength Index (RSI) 62.14 70.58
Support Level $32.03 $42.87
Resistance Level $37.23 $79.27
Average True Range (ATR) 0.53 2.57
MACD 0.37 1.70
Stochastic Oscillator 95.16 99.41

Price Performance

Historical Comparison
SNN
AFRM

About SNN Smith & Nephew SNATS Inc.

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

About AFRM Affirm Holdings Inc.

Founded in 2012, Affirm is a market leader in the buy-now, pay-later space with around $36 billion in transaction volume in fiscal 2025. Affirm offers both zero-interest financing, which is merchant subsidized, and interest-bearing loans, which function as personal loans that are approved on a per-transaction basis. Over 70% of Affirm's transaction volume comes from its interest-bearing loans, which also comprise the majority of its revenue. Affirm operates in the United States, which accounted for more than 95% of its revenue in 2025, but the firm has also expanded to Canada and the United Kingdom.

Share on Social Networks: